A meta-analysis of nivolumab for the treatment of advanced non-small-cell lung cancer

BACKGROUND: Non-small-cell lung cancer (NSCLC) is often associated with rapid progression following standard chemotherapy. Nivolumab, an inhibitor of PD-1/PD-L1, is reported to have potential efficacy for the treatment NSCLC. OBJECTIVE: The purpose of this meta-analysis was to systematically evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shuo, Hu, Bin, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217212/
https://www.ncbi.nlm.nih.gov/pubmed/30464517
http://dx.doi.org/10.2147/OTT.S171072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217212/
https://www.ncbi.nlm.nih.gov/pubmed/30464517
http://dx.doi.org/10.2147/OTT.S171072

Ejemplares similares